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ABSTRACT
CRISPR–Cas (clustered regularly interspaced short
palindromic repeats-CRISPR-associated) systems
provide adaptive immunity against invasive nucleic
acids guided by CRISPR RNAs (crRNAs) in archaea
and bacteria. Type III CRISPR–Cas effector com-
plexes show RNA cleavage and RNA-activated DNA
cleavage activity, representing the only known sys-
tem of dual nucleic acid interference. Here, we in-
vestigated the function of Cmr1 by genetic assays of
DNA and RNA interference activity in the mutants
and biochemical characterization of their mutated
Cmr complexes. Three cmr1α mutants were con-
structed including 1 , 1-M1 and 1-M2
among which the last two mutants carried a double
and a quadruple mutation in the first -helix region
of Cmr1 . Whereas the double mutation of Cmr1
(W58A and F59A) greatly influenced target RNA cap-
ture, the quadruple mutation almost abolished crRNA
binding to Cmr1 . We found that Cmr2-6 formed
a stable core complex that is active in both RNA and
DNA cleavage and that Cmr1 strongly enhances the
basal activity of the core complex upon incorpora-
tion into the ribonucleoprotein complex. Therefore,
Cmr1 functions as an integral activation module in
III-B systems, and the unique occurrence of Cmr1 in
III-B systems may reflect the adaptive evolution of
type III CRISPR–Cas systems in thermophiles.
INTRODUCTION
CRISPR–Cas (clustered regularly interspaced short palin-
dromic repeats, CRISPR- associated) systems are com-
posed ofCRISPR loci and cas gene cassettes, which code for
CRISPR RNAs (crRNAs) and Cas proteins, respectively.
The system mediates the small RNA-guided nucleic acid
interference to defend against invasive genetic elements in
archaea and bacteria (1–4). There are three distinct stages
in the adaptive immunity: adaptation, crRNA biogenesis
and invading nucleic acid (NA) interference. In the first
stage, two nucleases (Cas1 and Cas2) are required for ac-
quisition of new spacers in all tested bacteria and archaea,
which function together with some type-specific Cas pro-
teins (5,6). At the second step, CRISPR loci are expressed
as long precursor RNAs from which mature crRNAs are
generated (7). During the final interference stage, mature cr-
RNA and Cas proteins form a ribonucleoprotein complex
(crRNP) that recognizes incoming foreign DNA (or RNA)
by their sequence complementarity with crRNAand targets
the homologous sequence for cleavage (8).
In the latest classification scheme, CRISPR–Cas systems
fall into two main classes based on the number of Cas pro-
teins required for invading NA silencing. Whereas multi-
ple Cas proteins are required for NA interference in class 1
CRISPR–Cas systems, only a single Cas protein is required
by each of class 2 systems (2). At least six different types
of CRISPR–Cas systems are known (1,2) among which
only type III systems have been shown to mediate dual
DNA and RNA interference and their DNA interference is
transcription-dependent (9–12). Several type III ribonucle-
oprotein complexes (RNPs) have been isolated and charac-
terized, and all tested RNPs show the RNA-activated DNA
cleavage activity (12–16). Furthermore, theDNA shredding
activity can be strongly elevated when substrate DNA is
present in a large excess amount (16).
All known type III-BCmr complexes of dualNA interfer-
ence contain six Cmr proteins that form RNPs containing
crRNAs of two distinct sizes, i.e. 39 nt and 45 nt inPyrococ-
cus furiosus Cmr (PfuCmr) and 40 nt and 46 nt in Thermus
thermophilusCmr (TthCmr) and Sulfolobus islandicusCmr-
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 (SisCmr-) (16–19). In a structural model of PfuCmr
based on structures of individual Cmr proteins (20) and a
near-atomic resolution of TthCmr structure solved by cryo-
electron microscopy reconstructions (21), Cmr1 is an in-
tegral part of each effector complex. Nevertheless, a sta-
ble hybrid Cmr complex lacking Cmr1 has been obtained
and used for determination of the first crystal structure for
a type III effector complex (22). Furthermore, it has been
shown that crRNAbinding requires only fourCmr proteins,
i.e. Cmr2–5, but target RNA binding requires the two ad-
ditional proteins, Cmr1 and Cmr6 (23). In addition, Cmr
complexes lacking Cmr1 are functional in RNA cleavage
(22,24). Together, this has raised a question about whether
Cmr1 has an essential role in III-B CRISPR–Cas systems.
We employ S. islandicus REY15A (25) as the model for
investigation of CRISPR mechanisms since a comprehen-
sive array of genetic tools has been developed for this ar-
chaeon (26). Genetic tools developed for studying CRISPR
mechanisms include invader plasmid assays for DNA in-
terference by different CRISPR–Cas systems (9,27), an ar-
tificial mini-CRISPR-based RNA interference assay (10)
and in vivo site-directed gene mutagenesis using endoge-
nous CRISPR–Cas systems (26,28). The archaeon contains
a complete I-A CRISPR–Cas system and two III-B Cmr
modules named Cmr- and Cmr- all of which have been
characterized. The I-A system has been shown to mediate
the Protospacer Adjacent Motif (PAM)-dependent DNA
interference (27,29) and is active in adaptation of new spac-
ers (30). The Cmr- system confers dual DNA and RNA
interference (10) and theDNA interference is transcription-
dependent (9) whereas the Cmr- system only mediates
RNA interference (10).
Here, we aimed to investigate the functions of Cmr1 in
the dual DNA/RNA interference by the S. islandicus Cmr-
. Mutants of cmr1α gene deletion and amino acids sub-
stitutions were conducted and employed for in vivo genetic
analysis on Cmr- function and for biochemical charac-
terization of Cmr- complex isolated from each mutant.
We found that Cmr1 functions as an activation module
in Cmr- to strongly enhance its activity and the protein
achieves the activation by strongly binding to both target
RNA and crRNA.
MATERIALS AND METHODS
Strains, growth conditions and transformation of Sulfolobus
All Sulfolobus strains were derived from the original isolate
S. islandicusREY15A (31). S. islandicus E233 and were
reported previously (28,32).Mutants of cmr1α deletionmu-
tant and two alanine-substitutionmutations were generated
by following the CRISPR-based genome-editing method
recently developed in our laboratory (28). Genetic hosts and
plasmids employed in this work are listed in Supplemen-
tary Tables S1 and S2, respectively. S. islandicus strains were
grown at 78◦C in SCV medium (basic salts plus 0.2% su-
crose, 0.2% casamino acids plus 1% vitamin solution) or
SCVy (SCV + 0.0025% yeast extract), with uracil supple-
mented to 20 g/ml if required. Sulfolobus competent cells
were prepared and transformed by electroporation as pre-
viously described (32).
Construction of plasmids
Protospacer SS1 of the lacS gene was employed for gene
silencing previously using a plasmid carrying an artificial
CRISPR array containing SS1 spacer (10). Genome-editing
plasmids were constructed as described previously (28) us-
ing the oligonucleotides listed in Supplementary Table S3.
Sulfolobus expression vector pSeSD1 (33) was employed for
construction of a C-terminal 10xHis-tagged cmr6α by in-
serting its coding sequence into the vector at the NdeI and
StuI sites. Then, the fusion gene was amplified by PCR
using the primer pair of MCS-fwd and MCS-rev (Sup-
plementary Table S3). The resulting PCR product was di-
gested with SmaI and XhoI, and inserted into pAC10-SS1
(Supplementary Table S2) at SalI and SmaI sites, giving
pAC-cmr6-10His. All the oligonucleotides were synthe-
sized fromTsingke (Wuhan, China) and the sequences of all
plasmid constructs were verified by DNA sequencing (Ts-
ingke, Wuhan, China).
Determination of in vivoRNA interference efficiency by qRT-
PCR
Total RNAs were prepared from three transformants of
each mutant harboring either pAC-SS1 or pSe-Rp (A600 =
0.3, absorbance at 600 nm) as described previously (34). 1
g RNA was treated with DNase I (Thermo Fisher Scien-
tific) in a total volume of 20l fromwhich 2l treatedRNA
was used for generating complementaryDNA (cDNA)with
the RevertAid Reverse Transcriptase (Thermo Scientific)
using the lacS-RT-R primer aligning to a downstream posi-
tion of the lacS gene (Figure 1A, Supplementary Table S3).
Two primer sets, Qtar and Qref that were designed for ampli-
fication of PCR products in the target region and in a refer-
ence region of the mRNA, respectively, were employed for
PCR amplification using iTaq™ Unicersal SYBR® Green
Supermix (Bio-Rad) and a CFX384 Real-Time System
(Bio-Rad) with the following PCR condition: denaturing
at 95◦C for 5 min, 40 cycles of 95◦C 15 s, 55◦C 15 s and
72◦C 20 s. Data analysis was performed using the compar-
ative Ct value method (35). The amount of uncut mRNA
is expressed as the ratio between the amount of SS1 RNA
protospacer in pAC-SS1 transformants and that in the cor-
responding pSe-RP transformants.
Purification of Cmr- crRNA ribonucleoprotein complex
S. islandicus strains (,1,1M1 and1M2)
carrying pAC-cmr6-10His were grown in SCVy medium,
and cells were collected from at least 6 L of culture for each
strain by centrifugation when A600 of the culture reached
0.7–0.8. Cell pellet was re-suspended in Buffer A (20 mM
HEPES pH 7.5, 20 mM Imidazole, 250 mMNaCl) and dis-
rupted by French press and centrifuged for 30 min at 12 000
rpm. Supernatant was loaded onto a 1 ml HisTrap HP col-
umn (GE Healthcare) pre-equilibrated with Buffer A. Af-
ter washing with 15 ml of Buffer A, protein bound to the
column was eluted with linear gradient of imidazole (20–
500 mM) generated by mixing Buffer A and Buffer B (20
mM HEPES pH 7.5, 500 mM Imidazole, 250 mM NaCl).
Sample fractions were analyzed by SDS-PAGE, and those
containing Cmr- effector complexes were pooled together,
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Figure 1. Effect of cmr1 deletion on RNA and DNA interference by Cmr- in S. islandicus. (A) Schematic of in vivo RNA interference activity assay in
S. islandicus using artificial CRISPR plasmids (pAC). pAC-SS1, an artificial mini-CRISPR plasmid producing a crRNA that guides Cmr- proteins to
target the SS1 protospacer of lacS mRNAs for degradation. Two primer sets, Qtar and Qref designed for amplification of PCR products from the target
region and a reference region, respectively, are indicated on the lacS mRNA. (B) Quantification of mRNAs expressed from the chromosomal lacS gene
in different S. islandicus strains by qRT-PCR. Total RNAs were extracted from transformants of pAC-SS1 and pSe-RP, the latter of which a Sulfolobus
artificial mini-CRISPR cloning vector (reference plasmid), and lacS mRNA levels were estimated by qRT-PCR. Error bars represent standard deviations
of replicates determined for three independent transformants for each plasmid. Amounts of uncut mRNA are determined as the ratio of the amounts of
SS1 RNA protospacer in pAC-SS1 transformants versus those determined for the corresponding pSe-RP transformants. (C) In vivo DNA interference
activity assayed in different S. islandicus strains by an invader plasmid assay. pSeSD1––a shuttle vector for Sulfolobus, pS10i––an invader plasmid carrying
a target sequence of spacer 10 in CRISPR locus 2 in S. islandicusREY15A.––S. islandicus: a reference strain that carries a deletion of the complete
Cmr- gene cassette; 1––S. islandicus 1: derived from S. islandicus  from which the cmr1 gene was deleted. All strains were derived from
the genetic host S. islandicus E233 that carries the -glycosidase (lacS) gene.
concentrated and further purified by size exclusion chro-
matography in Buffer C (20 mMTris–HCl pH 8.0, 500 mM
NaCl) with a Superdex 200 Hiload column (GE Health-
care). After SDS-PAGE analysis, the fractions containing
the complete set of Cmr- subunits were pooled together
and concentrated. The purified Cmr- complexes were used
for further analysis.
Extraction and analysis of crRNA from the Cmr- ribonu-
cleoprotein complex
One hundred microliters of purified Cmr- complexes
(about 10 g protein for each) were mixed with 600 l Tri-
zol agent (Sigma) and 300 l chloroform in the indicated
order. After incubation at room temperature for 5 min, the
mixture was centrifuged at 12 000 rpm for 15 min. The up-
per phase was transferred into a new tube and precipitated
by one volume of isopropanol, and RNA precipitants were
recovered as a pellet by centrifugation. After washing with
1 ml of 75% ethanol pre-chilled on ice, the RNA pellet was
air-dried for 30 min at room temperature, dissolved in 15 l
DEPC-H2O, and used for further analysis.
An aliquot of the purified crRNA was first 5′ labeled by
32P- -ATP (PerkinElmer) using T4 polynucleotide kinase
(Thermo Fisher Scientific), and then separated on a large
denatured polyacrylamide gel (12%, 40 cm long, containing
40% urea). The labeled RNAs were identified by exposing
the gel to a phosphor screen (GE Healthcare), and scanned
by using a Typhoon FLA 7000 laser scanner (GE Health-
care). RNA ladders were generated by Decade™ Marker
RNA (Ambion) and labeled by 32 P with T4 polynucleotide
kinase.
Labeling of DNA and RNA substrates
DNA and RNA substrates used in cleavage assays were
5′ labeled with 32P- -ATP using T4 polynucleotide kinase
(Thermo Fisher Scientific). All nucleic acids were purified
by recovering the corresponding bands from a denaturing
polyacrylamide gel. DNA and RNA oligonucleotides to be
used as substrate for cleavage assays were purchased from
IDT, USA.
RNA cleavage and DNA cleavage assay
RNA and DNA cleavage assays were conducted as de-
scribed previously (16). The reaction mixture (10 l in to-
tal) contains 50 mM Tris–Cl (pH 7,6), 10 mM MgCl2, 5
mMDTT, and indicated amount of complex and substrates.
In the DNA cleavage assay, 200 nM (unless otherwise in-
dicated) unlabeled RNA was supplemented into the reac-
tionmixture to activateDNAcleavage activity. The reaction
was performed at 70◦C and stopped at the indicated time
point by the addition of 2 × RNA loading dye (New Eng-
land Biolabs) and cooling on ice. Finally, the samples were
heated for 5 min at 95◦C and separated on denaturing poly-
acrylamide gels (18% polyacrylamide, 40% urea) and visu-
alized by phosphor imaging using the Typhoon laser scan-
ner. Amounts of RNA/DNA products and remaining NA
substrates in each assay were extracted from the images us-
ing the Image Quant TL analysis software of the Typhoon
scanner. The percentage was normalized by those present
in reaction without Cmr- effector complex and averaged
with three times measurement.
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Target RNA binding assay
The binding assay was conducted with the amounts of Cmr-
 complex indicated in each assay with the binding buffer of
50mMTris–Cl (pH 7,6), 10mMMgCl2, 5mMDTT. 25 nM
of 32P-5′-labeled target RNA was added to each reaction
and incubated for 5 min at 70◦C. Then, 2 × RNA loading
dye was added to each reaction. The formation of Cmr–-
crRNA:target RNA tertiary complexes in the reactions was
detected by gel electrophoresis on a 10% non-denaturing
polyacrylamide gel. Radioactive signals were visualized by
phosphor imaging using the Typhoon FLA 7000 laser scan-
ner (GE Healthcare).
RESULTS
Depletion of Cmr1 by gene deletion eliminated in vivo
RNA interference and strongly impaired the transcription-
dependent DNA interference of Cmr- in S. islandicus
Previous studies show that Cmr effector complexes lacking
Cmr1 are either active or inactive in RNA cleavage in vitro
(14,17,22,24). To investigate whether Cmr1 could have an
essential function in vivo, we constructed a deletion mutant
of the corresponding gene in S. islandicus REY15A. The
strain carries two III-B Cmr modules named Cmr- and
Cmr-, both of which showed RNA interference activity in
a previous experiment (34). In order to eliminate any possi-
ble influence on functional analysis of Cmr1 by Cmr-, a
mutant devoid of the Cmr- systemwas constructed, giving
S. islandicus E233  (denoted ), and further deletion
of cmr1α yielded the mutant carrying cmr1 and Δcmr-
mutant alleles (1). The latter was suitable for genetic
analysis of Cmr1 function using  as a reference.
RNA interference in 1 was analyzed by the mini-
CRISPR assay reported previously (Figure 1A) (10). The
artificial CRISPR plasmid pAC-SS1 containing spacers
matching the lacS protospacer 1 (SS1) was introduced into
the double deletion mutant by electroporation, and the
amount of uncleaved lacSmRNA in the transformants were
determined by qRT-PCR with two sets of primer, Qtar and
Qref. Whereas qRT-PCR with the latter set of primer esti-
mates the total lacSmRNA level in the RNA preparations,
amplification with the former set of primer reveals the level
of uncut lacS mRNAs since the amplified region contains
the SS1 RNA protospacer, which is to be disrupted by Cmr-
RNAcleavage in the presence of SS1 crRNA.As shown in
Figure 1B, more than 90% of lacS mRNAs were cleaved in
the reference strain (S. islandicus) and at least 35%mR-
NAs retained in 1 cells. These results indicated that
depletion of Cmr1 by gene deletion strongly inhibited the
Cmr- RNA interference in the S. islandicus mutant.
The transcription-dependentDNA interference was eval-
uated by the invader plasmid assay (also called interference
plasmid assay), using an invader plasmid carrying an arti-
ficial protospacer of spacer 10 of CRISPR locus 2 in a re-
verse orientation (pS10i). As a result, transcription of S10i
on the plasmid produces a RNA protospacer that guides
DNA interference by III-B systems. The same invader plas-
mid was employed for studying Cmr-DNA interference in
a previous work (9). As shown in Figure 1C, whereas trans-
formation of the wild-type Cmr- strain () with pSeSD
yielded 2 × 105 transformants/g DNA, transformation
with pS10i did not give any transformants. In comparison,
whereas transformation of the doublemutantwith the refer-
ence plasmid showed a similar rate of transformation as for
the wild-type strain, transformation of 1 with the in-
vader plasmid gave ∼100-fold reduction in transformation
rate (Figure 1C). These data indicated that Cmr-1 should
play an important role in the Cmr-mediated DNA interfer-
ence in this crenarchaeon.
Cmr2-6 formed a stable core nucleoprotein complex in
vivo, exhibiting little residual RNA and DNA cleavage activ-
ity
Recently we have established a procedure to express a de-
fine crRNA and a His-tagged Cmr6 from pAC-cmr6 in
S. islandicus, and purify a native Cmr-RNP byHis-tagged
Cmr6 copurification (Supplementary Figure S1A, S1B).
The same expression plasmidwas introduced intoS. islandi-
cus 1 by electroporation, and the resulting transfor-
mants were used for isolating the Cmr- complex by the
two-step purification procedure. In gel filtration, theUV ab-
sorbance peak of the Cmr complex isolated from 1
appeared 0.5 ml later than that of the wild-type Cmr- (Fig-
ure 2A, 10.5 ml versus 11 ml), suggesting that the former
complex could be smaller in size than the latter. Analyz-
ing the protein components of the fractions collected in the
peak region showed that Cmr1 is indeed absent from the
Cmr- complex isolated from 1 (Figure 2B), indi-
cating that five Cmr proteins (Cmr2-6) formed protein
complex in vivo. The RNA component of the complex was
then examined by RNA extraction and radio-labeling of
the extracted RNA, and subsequently, denatured polyacry-
lamide gel analysis of the labeled products. As shown in Fig-
ure 2C, while the vast majority of crRNAs extracted from
the wild-type Cmr- complex were 40 and 46 nt in size, cr-
RNAs present in Cmr-1 were smaller in size: majority
of crRNAs appeared as a sequencing ladder from 28–35 nt,
although RNA bands of 46 nt and 40 nt were still visible.
These results suggested that crRNA could be more vulner-
able to exonuclease degradation in the absence of Cmr1.
Nevertheless, the data showed that the effector complex
formed by Cmr2-6 contains crRNAs (Figure 2C). The
ribonucleoprotein complex was designated Cmr-1 and
characterized.
First, we analyzed the in vitro RNA cleavage by Cmr-
1 as described previously since the effector complex only
contained a single type of crRNAs matching the lacS SS1
protospacer (Supplementary Table S4). First, SS1–46 RNA
was radio-labeled at 5′-end, which is complementary to the
spacer region of the crRNA but has mismatches to the 5′-
handle sequence of cRNA (Figure 2D). Then the labeled
RNA was incubated with either Cmr- or Cmr-1 for
the indicated times and analyzed by denaturing gel elec-
trophoresis. As shown in Figure 2E, the wild-type Cmr-
cleaved majority of RNA substrate within 1 min incubation
whereas Cmr-1 produced weak signals of multiple RNA
cleavage products after 30min incubation. Indeed, quantifi-
cation of uncleaved RNA substrate revealed that ca. 85% of
RNA substrate was retained in the Cmr-1 cleavage reac-
tion, indicative of a low RNA cleavage activity. These data
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Figure 2. The core Cmr- complex lacking Cmr1 is active in nucleic acid interference. (A) Gel filtration profiles of Cmr- (blue) and Cmr-1 (red). The
latter is composed of Cmr2–6.A280: UV absorbance at 280 nm. (B) SDS-PAGE analysis of purified Cmr- and Cmr-1 complexes. (C) crRNAs present
in Cmr- and Cmr-1 complexes. RNAs were extracted from Cmr- and Cmr-1, 5′-labeled with radio-active  -32P-ATP and analyzed by denaturing
PAGE. Ladder: RNA size ladder (nt). (D) Schematic of cleavage sites on SS1–46 RNA by Cmr- complex. (E) RNA cleavage assay. 50 nM Cmr- and
Cmr-1 complexes were incubated with 25 nM labeled SS1–46 RNA for indicated time points. Then, the samples were analyzed by denaturing PAGE.
(F) RNA-activated DNA cleavage assay. Each reaction contained 25 nM of labeled ssDNA, 200 nM SS1–46 RNA and 50 nM effector complex. After
incubation at 70◦C for 1 h, cleavage products were analyzed by denaturing PAGE.
suggested that the Cmr1 subunit is very important for the
backbone RNA cleavage by Cmr-.
The RNA-activated DNA cleavage by Cmr-1 was
then tested using a non-specificDNA substrate, S10 ssDNA
that does not match the crRNA in the ribonucleoprotein
complex (Supplementary Table S4). The reaction was set up
with 200 nM SS1–46 RNA, 25 nM S10 ssDNA and 50 nM
Cmr- complexes and incubated for 60 min during which
samples were taken at different time points. The reaction
was stopped by addition of the loading buffer, and the cleav-
age products were analyzed by denaturing gel electrophore-
sis. As shown in Figure 2F, Cmr- and Cmr-1 showed
the same pattern of DNA cleavage. Quantification of resid-
ual DNA substrate in each reaction revealed that, while
wild-type Cmr- cleaved ∼55% of DNA substrate within 5
min, it required 60 min for Cmr-1 to cleave 58% of DNA
substrate. These results indicated that Cmr-1 represents
a core III-B effector complex that shows both RNA and
DNA cleavage activity in vitro and transcription-dependent
DNA interference in vivo.
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Substitution mutation of a few well-conserved amino acids in
Cmr1 exerted different effects on DNA and RNA interfer-
ence by Cmr- in S. islandicus
Multiple sequence alignments of a few Cmr1 proteins re-
vealed several highly conserved amino acids in the first al-
pha helix of the protein (Supplementary Figures S2 and S3).
Using the SWISS-MODELweb-server (36–39), a structural
model was generated for the S. islandicus Cmr1 protein
based on the structure of AfCmr1 (PDB id. 4l6u) (40) and
PfCmr1 (PDB id. 4w8x) (20). Two groups of highly con-
served amino acids were identified in the Cmr1 structural
model: the first one containing two hydrophobic amino
acids (W58 and F59, positions in S. islandicus Cmr1) that
were found to bind nucleotides in a previous study (20),
and the other group of four invariant amino acids (I52,
G54, R57 and R61) that positioned differently in the model
(Supplementary Figure S3). Since the hand-like groove was
predicted to bind RNA in Cmr1, each set of amino acids
was subjected to substitution mutagenesis using a recently
developed CRISPR-based in vivo gene mutagenesis. Trans-
formation of S. islandicus  with each genome-editing
plasmid (Supplementary Table S2) yielded cmr1α mutant 1
(1-m1) coding for Cmr1W58AF59A and cmr1α mutant
2 (1-m2) coding for Cmr1I52AG54AR57AR61A (Supple-
mentary Figure S4).
The two mutants were then employed for investigating
RNA interference and transcription-dependent DNA in-
terference together with the wild-type reference (the 
strain). We found that, while pAC-SS1-guided RNA inter-
ference strongly reduced lacS mRNA (95%) in the wild-
type Cmr- strain RNA interference, it reduced the target
RNAs by 70% and 50% in1-m1 and1-m2, respec-
tively (Figure 3A). The 1-m2 mutant was still active in
RNA interference albeit at a lowered level, which showed
similarity to the system present in the cmr1 deletion mu-
tant (1, Figure 1A). These results indicated that the
two hydrophobic amino acids (W58, F59) in the 1 helix
could be very important for the Cmr- RNA interference
whereas the four invariant amino acids should have an es-
sential function inRNA interference byCmr- (Figure 3A).
Together, these data suggested that the surface groove in
Cmr1 could have multiple functions in RNA interference.
We also employed the invader plasmid assay to test the
transcription-dependentDNA interference by the III-B sys-
tem in both cmr1α mutants. Strikingly, transformation of
the wild-type Cmr- strain and 1-m1 with the invader
plasmid produced no or very few colonies whereas transfor-
mation of 1-m2 with the same plasmid gave hundreds
fold higher transformation rate (Figure 3B). Nevertheless,
the transformation efficiency with 1-m2 is still hun-
dreds fold lower than that obtained with the cloning vector
pSeSD, a reference plasmid (Figure 3B). These results indi-
cated that, whereasW58A and F59A substitution in Cmr1
did not influence the transcription-dependent DNA inter-
ference by the Cmr- system, mutation of the four invari-
ant amino acids (I52A, G54A, R57A and R61A) strongly
impaired the DNA interference activity.
Mutant Cmr- complex exhibited distinctive RNA and DNA
cleavage activity in vitro
To gain a further insight into the function of Cmr1 in an-
tiviral immunity by Cmr-, RNP was purified from each
mutant by following the procedure described for purifica-
tion of the Cmr- complex. We found that profiles of UV
absorbance in the gel filtration purification fell into two dis-
tinct groups: while the profile of theCmr- complex purified
from the 1-m1 mutant was very similar to that of the
wild-type effector complex, the UV profile of the effector
complex obtained from 1-m2 resembled that of Cmr-
1 (Supplementary Figure S5A). These two mutant com-
plexes were named as Cmr-1M1 and Cmr-1M2, respec-
tively, and further characterized.
SDS-PAGE analysis of Cmr-1M1 and Cmr-1M2
showed that a protein band corresponding to Cmr1 was
present in the former but could be hardly detected in the lat-
ter (Supplementary Figure S5B). Analysis of their crRNAs
revealed that crRNAs extracted from Cmr-1M1 resem-
bled those present in the wild-type Cmr- whereas crRNAs
present in Cmr-1M2 resembled those isolated from Cmr-
1 (Supplementary Figure S5C). These results suggested
that, whileW58A and F59A substitutions in Cmr1 did not
affect the capability of the protein to form RNP, substitu-
tion of I52A G54A R57A and R61A strongly impaired the
interaction between Cmr1 and other components of the
RNP, either Cmr proteins or crRNA.
Bothmutant Cmr- effector complexes were analyzed for
RNA cleavage using a radio-labeled SS1–46 RNA substrate
as for Cmr-1. To better assess the cleavage activity of
Cmr-1M1 and Cmr-1M2, 50 nM of the enzyme was used
in RNA cleavage reaction for each mutant complex. Cleav-
age products were analyzed by denaturing gel electrophore-
sis and the results were shown in Figure 3C. Quantification
of the cleavage products revealed that, after 1 min incuba-
tion, up to 80% of RNA substrate was cleaved by the wild-
typeCmr-whereas only 5%ofRNAsubstratewas destruc-
ted by Cmr-1M1 and Cmr-1M2. Nevertheless, both mu-
tant complexes showed RNA cleavage, and the pattern of
RNA cleavage remained the same.
Both mutant effector complexes were then assayed for
their RNA-activated DNA cleavage activity using a radio-
labeled S10 ssDNA as the substrate. Again, 50 nM of Cmr1
mutant complex was used in each assay. As shown in Figure
3D, weaker DNA cleavage activity was observed for each
mutant complex. Quantification of uncleaved DNA sub-
strate showed that ca. 50% of ssDNA was cleaved by the
WT Cmr- in 5 min, <5% of DNA substrate was cleaved
by Cmr-1M1 and Cmr-1M2. After incubation of 60 min,
additional 40% of ssDNA was cleaved by each of the Cmr
complexes. Furthermore, these results suggested that the
two sets of amino acids inCmr1 should have different roles
in NA cleavage by the effector complex.
To yield an insight into whether Cmr1 could influence
the RNA and DNA cleavage via RNA binding, an elec-
trophoretic gel mobility shift assay was employed to exam-
ine the interaction between the target RNA and different
types of Cmr- effector complexes purified in this work,
including Cmr-, Cmr-1, Cmr-1M1 and Cmr-1M2.
As shown in Figure 4, only Cmr-1 was not capable of
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Figure 3. Influence of Cmr1 RNA-binding activity on the in vivo nucleic acid interference and in vitro RNA/DNA cleavage by the Cmr- system. RNA
interference (A) and transcription-dependent DNA interference (B) were determined for the cmr1mutants as described in the legends of Figure 1B and C.
RNA cleavage activity (C) and RNA-activated DNA cleavage activity (D) were assayed as described in the legends of Figure 2C and D. ––S. islandicus
, a reference strain carrying a deletion of the complete Cmr- gene cassette; 1-M1––S. islandicus 1-M1: derived from S. islandicus  with
which substitution mutations of W58A and F59A were generated on the cmr1 gene. 1-M2––S. islandicus 1-M2: derived from S. islandicus 
with which substitution mutations of I52A, G54A, R57A and R61A were generated on the cmr1 gene. Cmr-1M1: mutant Cmr- complex purified from
S. islandicus1-M1 (containing Cmr1W58A,F59A); Cmr-1M2: mutant Cmr- complex purified from S. islandicus1-M2 (carrying amuch reduced
level of Cmr1I52A, G54A, R57A,R61A).
forming any stable RNP::target RNA tertiary complexes
under the experimental conditions. Furthermore, tertiary
complexes formed by the remaining three RNPs showed
different stabilities: The super-complexes formed by 10 nM
Cmr- were comparable to those formed by 160 nM Cmr-
1M1 and those by 320 nM Cmr-1M2 (Figure 4). These
data indicated that the first -helix domain of Cmr1 plays
a very important function in anchoring cognate target RNA
in the effector complex of III-B Cmr- system.
Another important feature for the S. islandicus Cmr-
system is that the effector complex is capable of mediating
massive DNA destruction (16). To investigate if the activity
is Cmr1 dependent, we tested whether Cmr-1M1 could
exert the massive ssDNA cleavage activity recently revealed
for the wild-type Cmr- except that 8-fold of Cmr-1M1
was used in the assay. As shown inFigure 5, very similar pat-
terns of DNA cleavage were observed for substrate concen-
trations of 100-fold difference for both the wild-type RNP
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Figure 4. Conserved amino acids in the Cmr1 ribonucleotide-binding
groove are important for target RNA binding. Twenty-five nM of labeled
SS1–46 RNA was mixed with the amounts of Cmr-, Cmr-1M1, Cmr-
1M2 or Cmr-1 indicated in each experiment. After incubation for 15
min, 2× loading buffer was added to each reaction. The samples were
then analyzed by non-denaturing polyacrylamide gel electrophoresis. The
amounts of effector complex used in the assay are: 10–80 nM Cmr-, 20–
160 nM Cmr-1M1, 40–320 nM Cmr-1M2 or Cmr-1. Duplex: RNA
complex of crRNA and target RNA; Bound: Cmr--crRNA:target RNA
tertiary complexes.
Figure 5. Cmr1-M1 does not impact the massive DNA cleavage of Cmr-
 complex. Twenty-five nM labeled S10 ssDNA substrate were incubated
with 50 nMCmr-/400 nMCmr-1M1 and 200 nMSS1RNA, in the pres-
ence or absence of 2.5 Mof unlabeled S10 ssDNA as indicated. Reaction
was conducted for 60 min during which samples were taken at 5, 30 and 60
min and analyzed by denaturing PAGE.
and the mutant RNP. These results indicated that reduction
of target RNA binding did not impair the massive ssDNA
destruction by the Cmr- system.
In conclusion, our genetic and biochemical studies on the
S. islandicus Cmr- system have revealed that Cmr1 is not
essential for NA interference by the III-B Cmr- system but
the protein strongly facilitates the interference activity of
the antiviral system and the stimulation depends on Cmr1
binding activity to both crRNA and target RNA in the ef-
fector complex.
DISCUSSION
Recently, it has been shown that III-A and III-B sys-
tems mediate transcription-dependent DNA interference in
vivo whereas their effector complexes exert RNA-activated
DNA cleavage in vitro (reviewed in (12)). The active sites for
RNA and DNA cleavage have been identified. RNA cleav-
age occurs at each of the large subunits of the helical back-
bone in the complex (13–15,22), i.e. Cmr4 for III-B RNPs
and Csm3 for III-A effector complexes whereas active sites
for DNA cleavage reside on Cas10 (Cmr2/Csm1), the sig-
nature protein of type III CRISPR–Cas systems (13–16,41).
The RNA-activated DNA cleavage process is subjected to
a spatiotemporal regulation (15): (a) the binding of a cog-
nate target RNA to the corresponding binary RNP com-
plex yields a tertiary RNP complex that is an active DNase.
The formation of tertiary RNP involves a conformational
change that activates the DNase activity; (b) upon the tar-
get RNA cleavage and release of cleaved RNAproducts, the
tertiary status returns to the binary status that is an inactive
DNase. Furthermore, the S. islandicus Cmr- shows mas-
sive ssDNA destruction when DNA substrate is present in
a large amount (16).
Two active RNPs have been reported for several III-B
Cmr systems. The smaller ones have been reconstituted
with five different Cmr proteins (Cmr2–6) of P. furiosus,
T. thermophilus, T. maritima and a hybrid complex (com-
posed of PfCmr2dHD-Cmr3 and Cmr4-Cmr5-Cmr6 from
A. fulgidus), which, together with the native Cmr-1 com-
plex purified from S. islandicus in this work, are termed
as the core Cmr complex. Several core Cmr complexes are
reported to be active in RNA cleavage in vitro (14,17,22–
24). Consistent with these observations, Cmr-1, the core
complex of the S. islandicus Cmr- system is also active in
RNA cleavage. Here we have investigated in vivoRNA inter-
ference activity of the core Cmr- system using S. islandi-
cus 1, the cmr1 deletion mutant. Initially, the mini-
CRISPR-based reporter gene assay was employed to reveal
in vivoRNA interference in the cmr1 deletion mutant, but
it failed to reveal any activity (data not shown). Then, qRT-
PCR was employed to directly analyze the quantity of mR-
NAs of lacS, the reporter gene. RNA interference activity
was detected in these cmr1α mutants. Furthermore, the mu-
tant (1) is active in DNA interference as revealed by
invader plasmid assay, albeit at a level of 100-fold lower
than the activity present in the wild-type strain. To this end,
Cmr1 can be regarded as an integral activation module in
the Cmr- effector complex and functions in elevating both
RNA and DNA interference by the III-B system.
Comparative studies of the wild-type Cmr- and its three
Cmr1 mutant derivative complexes have yielded impor-
tant insights into the molecular mechanisms of Cmr1 acti-
vation. (a) Cmr1 stabilizes crRNA in the effector complex
since crRNAs in Cmr-1 are not only shorter, but also de-
generated, in contrast to the strictly 40 and 46 nt crRNAs
present in Cmr- (Figure 2C). (b) Cmr1 hosts the key in-
teraction between crRNA and its cognate target RNA since
a seed sequence identified by in vivo RNA interference as-
say for the S. islandicus Cmr- system is located in 28–30 nt
of crRNAs (10) interacts with Cmr1 proteins in all known
Cmr structural models (18–22). (c) We have shown that ala-
nine substitutions ofW58 and F59 in Cmr1 have not influ-
enced its capability of crRNA binding but greatly reduced
the interaction of the mutated effector complex with the
cognate target RNA (Figure 4). Further, it has been shown
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that theP. furiosus andThermotogamaritimaCmr1 proteins
do not interact with any other Cmr subunits in the absence
of crRNAs (14,23). Together these results indicate that the
Cmr subunit retains to III-B effector complexes by bind-
ing to crRNA and the well conserved hydrophobic amino
acids of W58 and F59 play a crucial role in crRNA bind-
ing. (d) We further show that purification of Cmr- com-
plex from the mutant (Cmr-1M2) carrying the quadruple
mutation of I52A, G54A, R57A and R61A of Cmr1 has
yielded an effector complex that is largely devoid of the mu-
tant Cmr1 subunit (only detectable in SDS-PAGE with a
large amount of sample) indicating that the interaction be-
tween Cmr-1M2 and crRNAs has greatly impaired by the
mutations. Furthermore, the Cmr-1M2 effector complex
shows a stronger affinity to the target RNA relative to Cmr-
1, suggesting that target RNA binding by Cmr-1M2 is
probably not weakened by the mutation. Therefore, it has
been reasoned that these amino acids are involved in cr-
RNA binding. Since all six characterized amino acids are
very well conserved among Cmr1 proteins and present in
the Cmr1 ribonucleotide-binding groove identified by struc-
tural analyses (Supplementary Figures S3 and S4), this sug-
gests that III-B CRISPR–Cas systems may share the mech-
anisms of crRNA and target RNA binding as well as the
function of Cmr1 as the activation module in the effector
complex as demonstrated for the S. islandicus Cmr- sys-
tem in this work.
Furthermore, in III-A effector complexes, there is only
one subunit, i.e. Csm5, in the corresponding position of
Cmr1 and Cmr6 in the III-B effector complexes. This raises
at least two interesting questions: (i) what is the function
of Cmr6 in Cmr complexes? (ii) Does Csm5 play the roles
of both Cmr1 and Cmr6 in III-A effector complexes or
III-A complexes represent a derivative of the core effector
complex of III-B complexes? Conduction of direct compar-
isons of these immune systems will help lead to the answers
of these questions. On the other hand, investigation of the
diversity and distribution of CRISPR–Cas systems shows
that, while III-B systems are over-represented among ther-
mophiles, III-A systems predominate in mesophiles (2,42).
In this regard, there appears to be a correlation between the
Cmr1 occurrence and thermophilic life style of microorgan-
isms, and this may reflect the adaptive evolution of type III
CRISPR–Cas systems in thermophilic organisms.
To avoid self-immunity, the spatiotemporal regulation of
the RNA-activatedDNA cleavage by III-A and III-BRNPs
should only allow the ssDNA cleavage to be active very
briefly, and the DNase should be inactivated immediately
after target DNA cleavage by removing target RNA.Never-
theless, it remains to be investigated as to which Cmr/Csm
subunits are involved in the conformation change process
and how the conformation is controlled. The present work
has revealed that Cmr1 probably does not have a role in
the spatiotemporal regulation in III-B CRISPR–Cas sys-
tems. As a result, core III-B complexes provide useful ma-
terials for investigation of molecular mechanisms of the
RNA-activated DNA cleavage by III-B CRISPR–Cas sys-
tems such as the resolution of the crystal structure for a hy-
brid III-B core complex (22).
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